Sridhar Ramaswamy

55.1k total citations · 14 hit papers
141 papers, 28.9k citations indexed

About

Sridhar Ramaswamy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sridhar Ramaswamy has authored 141 papers receiving a total of 28.9k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 51 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Sridhar Ramaswamy's work include Cancer Cells and Metastasis (27 papers), Cancer Genomics and Diagnostics (22 papers) and Data Management and Algorithms (21 papers). Sridhar Ramaswamy is often cited by papers focused on Cancer Cells and Metastasis (27 papers), Cancer Genomics and Diagnostics (22 papers) and Data Management and Algorithms (21 papers). Sridhar Ramaswamy collaborates with scholars based in United States, India and Canada. Sridhar Ramaswamy's co-authors include Todd R. Golub, Kyuseok Shim, Rajeev Rastogi, Ken N. Ross, Eric S. Lander, Daniel A. Haber, Ben S. Wittner, Shyamala Maheswaran, Andrea L. Richardson and Robert A. Weinberg and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Sridhar Ramaswamy

138 papers receiving 28.2k citations

Hit Papers

Twist, a Master Regulator of Morphogenesis, Plays an Esse... 2000 2026 2008 2017 2004 2012 2013 2002 2010 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
    2004 3.1k citations Sridhar Ramaswamy, Andrea L. Richardson et al. Cell profile →
  2. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
    2012 2.6k citations Wanjuan Yang, Jorge Soares et al. Nucleic Acids Research profile →
  3. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
    2013 1.9k citations Min Yu, Aditya Bardia et al. Science profile →
  4. A molecular signature of metastasis in primary solid tumors
    2002 1.9k citations Sridhar Ramaswamy, Ken N. Ross et al. profile →
  5. A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
    2010 1.8k citations Sreenath V. Sharma, Diana Lee et al. Cell profile →
  6. Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
    2014 1.8k citations Aditya Bardia, David T. Miyamoto et al. Cell profile →
  7. Multiclass cancer diagnosis using tumor gene expression signatures
    2001 1.5k citations Sridhar Ramaswamy, Jill P. Mesirov et al. Proceedings of the National Academy of Sciences profile →
  8. Efficient algorithms for mining outliers from large data sets
    2000 1.2k citations Sridhar Ramaswamy et al. profile →
  9. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    2005 1.1k citations Sridhar Ramaswamy, Stephan N. Wagner et al. profile →
  10. Efficient algorithms for mining outliers from large data sets
    2000 780 citations Sridhar Ramaswamy et al. profile →
  11. A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells
    2012 626 citations Sridhar Ramaswamy et al. Cell profile →
  12. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma.
    2002 619 citations Sridhar Ramaswamy et al. profile →
  13. Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
    2015 615 citations Kenneth N. Ross, Myriam Boukhali et al. profile →
  14. Bcl2 Regulation by the Melanocyte Master Regulator Mitf Modulates Lineage Survival and Melanoma Cell Viability
    2002 578 citations Sridhar Ramaswamy et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sridhar Ramaswamy United States 58 16.4k 10.3k 7.0k 3.5k 3.0k 141 28.9k
Sayan Mukherjee United States 45 25.2k 1.5× 6.3k 0.6× 8.3k 1.2× 5.8k 1.7× 2.6k 0.9× 139 43.3k
Michael B. Eisen United States 72 42.7k 2.6× 12.5k 1.2× 13.0k 1.9× 3.6k 1.0× 2.7k 0.9× 161 62.0k
Pablo Tamayo United States 52 48.4k 3.0× 11.6k 1.1× 14.4k 2.1× 9.9k 2.8× 5.0k 1.7× 149 74.2k
Fabian J. Theis Germany 85 21.1k 1.3× 2.1k 0.2× 4.4k 0.6× 1.2k 0.3× 1.2k 0.4× 447 30.9k
Paul T. Spellman United States 40 21.9k 1.3× 3.9k 0.4× 3.9k 0.6× 1.3k 0.4× 1.9k 0.6× 114 31.1k
James R. Downing United States 83 26.7k 1.6× 6.0k 0.6× 9.9k 1.4× 1.8k 0.5× 1.9k 0.6× 269 43.9k
Todd R. Golub United States 111 77.0k 4.7× 18.8k 1.8× 27.5k 3.9× 13.7k 3.9× 5.1k 1.7× 229 113.9k
Dana Pe’er United States 58 14.7k 0.9× 5.0k 0.5× 2.9k 0.4× 1.9k 0.5× 1.4k 0.5× 120 23.2k
Stephen T.C. Wong United States 59 6.8k 0.4× 2.9k 0.3× 1.8k 0.3× 1.4k 0.4× 1.2k 0.4× 493 16.9k
Carlos Caldas United Kingdom 99 20.4k 1.2× 13.7k 1.3× 16.6k 2.4× 6.2k 1.8× 817 0.3× 533 41.2k

Countries citing papers authored by Sridhar Ramaswamy

Since Specialization
Citations

This map shows the geographic impact of Sridhar Ramaswamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridhar Ramaswamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridhar Ramaswamy more than expected).

Fields of papers citing papers by Sridhar Ramaswamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sridhar Ramaswamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridhar Ramaswamy. The network helps show where Sridhar Ramaswamy may publish in the future.

Co-authorship network of co-authors of Sridhar Ramaswamy

This figure shows the co-authorship network connecting the top 25 collaborators of Sridhar Ramaswamy. A scholar is included among the top collaborators of Sridhar Ramaswamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sridhar Ramaswamy. Sridhar Ramaswamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koh, Siang‐Boon, Kenneth N. Ross, Steven J. Isakoff, et al.. (2021). RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer. Clinical Cancer Research. 27(17). 4883–4897. 16 indexed citations
2.
Karaayvaz, Mihriban, Adam Langenbucher, Srinivas Vinod Saladi, et al.. (2020). Aneuploidy and a deregulated DNA damage response suggest haploinsufficiency in breast tissues of BRCA2 mutation carriers. Science Advances. 6(5). eaay2611–eaay2611. 26 indexed citations
3.
Ghosh, Srimoyee, Geeta Sharma, Jon Travers, et al.. (2018). TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade In Vitro and In Vivo. Molecular Cancer Therapeutics. 18(3). 632–641. 50 indexed citations
4.
Alves, Cleidson P., Ipsita Dey‐Guha, Sheheryar Kabraji, et al.. (2017). AKT1low Quiescent Cancer Cells Promote Solid Tumor Growth. Molecular Cancer Therapeutics. 17(1). 254–263. 19 indexed citations
5.
Facompre, Nicole D., Xavier Solé, Sheheryar Kabraji, et al.. (2016). JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral Cancers. Cancer Research. 76(18). 5538–5549. 37 indexed citations
6.
Sadelain, Michel, David Avigan, Priscilla K. Brastianos, et al.. (2015). Collaboration in Cancer Trials (October 26–27, 2015). The Oncologist. 20(S2). S1–S8. 2 indexed citations
7.
Yeh, Albert C. & Sridhar Ramaswamy. (2015). Mechanisms of Cancer Cell Dormancy—Another Hallmark of Cancer?. Cancer Research. 75(23). 5014–5022. 156 indexed citations
8.
Javaid, Sarah, Jianmin Zhang, Gromoslaw A. Smolen, et al.. (2015). MAPK7 Regulates EMT Features and Modulates the Generation of CTCs. Molecular Cancer Research. 13(5). 934–943. 35 indexed citations
9.
Solé, Xavier, Cleidson P. Alves, Ipsita Dey‐Guha, et al.. (2015). AKT Inhibition Promotes Nonautonomous Cancer Cell Survival. Molecular Cancer Therapeutics. 15(1). 142–153. 17 indexed citations
10.
McMullin, Ryan P., Ben S. Wittner, Chuanwei Yang, et al.. (2014). A BRCA1deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Research. 16(2). R25–R25. 43 indexed citations
11.
Bersani, Francesca, Jung Woo Lee, Min Yu, et al.. (2014). Bioengineered Implantable Scaffolds as a Tool to Study Stromal-Derived Factors in Metastatic Cancer Models. Cancer Research. 74(24). 7229–7238. 51 indexed citations
12.
Yu, Min, Aditya Bardia, Ben S. Wittner, et al.. (2013). Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition. Science. 339(6119). 580–584. 1928 indexed citations breakdown →
13.
Miyamoto, David T., Richard J. Lee, Shannon L. Stott, et al.. (2012). Androgen Receptor Signaling in Circulating Tumor Cells as a Marker of Hormonally Responsive Prostate Cancer. Cancer Discovery. 2(11). 995–1003. 217 indexed citations
14.
Yang, Wanjuan, Jorge Soares, Patricia Greninger, et al.. (2012). Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Research. 41(D1). D955–D961. 2597 indexed citations breakdown →
15.
Dey‐Guha, Ipsita, Anita Wolfer, Albert C. Yeh, et al.. (2011). Asymmetric cancer cell division regulated by AKT. Proceedings of the National Academy of Sciences. 108(31). 12845–12850. 101 indexed citations
16.
Lee, J., Ben S. Wittner, Morgan L. Maeder, et al.. (2011). Induction of Stable Drug Resistance in Human Breast Cancer Cells Using a Combinatorial Zinc Finger Transcription Factor Library. PLoS ONE. 6(7). e21112–e21112. 11 indexed citations
17.
Sharma, Sreenath V., Diana Lee, Bihua Li, et al.. (2010). A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations. Cell. 141(1). 69–80. 1828 indexed citations breakdown →
18.
Wittner, Ben S., Dennis C. Sgroi, Paula D. Ryan, et al.. (2008). Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort. Clinical Cancer Research. 14(10). 2988–2993. 115 indexed citations
19.
Xu, Lei, Steven S. Shen, Yujin Hoshida, et al.. (2008). Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases. Molecular Cancer Research. 6(5). 760–769. 195 indexed citations
20.
Alvarez, James V., Phillip G. Febbo, Sridhar Ramaswamy, et al.. (2005). Identification of a Genetic Signature of Activated Signal Transducer and Activator of Transcription 3 in Human Tumors. Cancer Research. 65(12). 5054–5062. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sayan Mukherjee Breakdown of academic impact, for papers by Michael B. Eisen Breakdown of academic impact, for papers by Pablo Tamayo Breakdown of academic impact, for papers by Fabian J. Theis Breakdown of academic impact, for papers by Paul T. Spellman Breakdown of academic impact, for papers by James R. Downing Breakdown of academic impact, for papers by Todd R. Golub Breakdown of academic impact, for papers by Dana Pe’er Breakdown of academic impact, for papers by Stephen T.C. Wong Breakdown of academic impact, for papers by Carlos Caldas
Rankless by CCL
2026